Cosette appeals loss over exit from $672M Mayne Pharma merger

M&A 2025-11-10 3:17 pm By Cat Fredenburgh

Cosette plans to appeal a ruling that rejected its bid to terminate an agreement to merge with Mayne Pharma, as the US drug company also refuses to agree to conditions needed to win Foreign Investment Review Board approval for the tie-up.